EGFR and non-small cell lung carcinoma: Even using a concentration 30-fold higher than the CC50 value for the EGFR mutant NSCLC cells (H1975 and HCC827) to treat CCD19-LU, there was still no significant inhibitory effect, implying low toxicity of P.A in normal lung fibroblast cells.